Fred Dejonckheere

Background

About Fred Dejonckheere

With an unconventional educational background spanning mathematics, medicine, health economics, and pharmaceutical marketing, I bring over 25 years of experience in the pharmaceutical industry as a scientific and business professional. I developed and implemented regulatory, medical, access, and commercial strategies at both national and global levels, enabling me to easily turn complex information from very different sources into clear, actionable strategies and well-grounded business decisions for a mixed audience of stakeholders.> 15 years of experience in Pipeline & Market Access Strategy - Devised and executed 4 Global Disease Area and Portfolio Strategies - ensuring alignment with overall business objectives, driving business focus, and identifying critical success factors - and 2 Global Pricing and Market Access Strategies, securing a unique competitive advantage in the market, leveraging decisively differentiating indirect comparisons - Critically assessed >10 in-licensing opportunities, as a trusted advisor to the Partnering organization, renowned for fast and well-documented analyses leading to unambiguous decisions >20 years of experience with Evidence & Insights Generation, Value Propositions and Launch Readiness - Played a pivotal role in the global re-positioning of a drug by conducting indirect comparisons with competitors demonstrating its superiority, and in the global re-launch of another one by showcasing a convincing mortality benefit and repurposing payer evidence for prescribers - Authored >5 (over 400 times cited) publications in collaboration with Key Opinion Leaders in medical journals, and presented >20 congress abstracts, posters, and podium presentations highlighting patient-relevant, differentiating features, significantly driving treatment adoption - Pioneered innovative thinking and tools on beyond-brand or controversial topics like gene therapies in larger indications, symptomatic treatment, and oral devices for biologics and peptides >25 years of experience with Cross-Functional Collaboration & Stakeholder Engagement - Engaged national Key Opinion Leaders (KOLs) in multiple global clinical trial programs, resulting in their recognition as top recruiters (both qualitative and quantitative)- Designed dozens of customer-centric Target Product Profiles aligning both internal and external stakeholder interests in both rare and non-rare indications across various therapeutic areas - Secured regulatory approval for business-critical label and artwork changes deemed unfeasible